|
US3238215A
(en)
*
|
1963-10-17 |
1966-03-01 |
Sterling Drug Inc |
1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
|
|
BE665245A
(de)
*
|
1964-06-11 |
|
|
|
|
US3412097A
(en)
*
|
1964-09-07 |
1968-11-19 |
Koninklijke Pharma Fab Nv |
Indole derivatives
|
|
US3471499A
(en)
*
|
1965-12-03 |
1969-10-07 |
American Home Prod |
1,4-bis-(2-indol-3-yl-ethyl)piperazines
|
|
US3984437A
(en)
*
|
1969-09-03 |
1976-10-05 |
Mitsubishi Chemical Industries Ltd. |
Basic dyestuff
|
|
SU516354A3
(ru)
*
|
1970-03-07 |
1976-05-30 |
Краковски Заклады Фармацеутичне"Польфа" (Инопредприятие) |
Способ получени пиридиламидов фуранкарбоновой кислоты или их солей
|
|
US4028365A
(en)
*
|
1970-09-03 |
1977-06-07 |
John Wyeth & Brother Limited |
Benz[g]indolyl compounds
|
|
US4160862A
(en)
*
|
1972-06-12 |
1979-07-10 |
Sterling Drug Inc. |
1-Acyl-3-(amino-lower-alkyl)indoles
|
|
GB1374414A
(en)
*
|
1972-06-12 |
1974-11-20 |
Sterling Drug Inc |
1-acyl-3-amino-alkyl-indoles and their preparation
|
|
US4024147A
(en)
*
|
1972-06-30 |
1977-05-17 |
John Wyeth & Brother Limited |
Heterocyclic compounds
|
|
US4061758A
(en)
*
|
1972-06-30 |
1977-12-06 |
John Wyeth & Brother Limited |
Treating hypertension and central nervous system abnormalities
|
|
US3869463A
(en)
*
|
1973-01-17 |
1975-03-04 |
Wyeth John & Brother Ltd |
N-phenyl derivatives of alkanoylamido piperidines
|
|
DE2322470A1
(de)
*
|
1973-05-04 |
1974-11-21 |
Boehringer Sohn Ingelheim |
Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
|
|
GB1413708A
(en)
*
|
1973-06-19 |
1975-11-12 |
Wyeth John & Brother Ltd |
Indole derivative
|
|
US4177279A
(en)
*
|
1973-10-10 |
1979-12-04 |
John Wyeth & Brother Ltd. |
1-[(3-Indolyl)-alkyl]-piperidyl ureas and hypotensive compositions
|
|
US4061641A
(en)
*
|
1973-10-10 |
1977-12-06 |
John Wyeth & Brother Limited |
Ureidopiperidino-ketoalkyl indoles
|
|
GB1459506A
(en)
*
|
1974-02-18 |
1976-12-22 |
Wyeth John & Brother Ltd |
Piperidine derivatives
|
|
US3936464A
(en)
*
|
1974-10-25 |
1976-02-03 |
American Cyanamid Company |
1-Acyl-3-[2-(4-phenyl-1-piperidinyl)ethyl]indolines
|
|
US4026938A
(en)
*
|
1974-12-27 |
1977-05-31 |
Sterling Drug Inc. |
1-Phenyl-3-azacarbocyclic-ureas
|
|
ZA76475B
(en)
*
|
1975-03-10 |
1977-08-31 |
Ciba Geigy Ag |
Indolyalkylpiperidines
|
|
GB1498884A
(en)
*
|
1975-04-15 |
1978-01-25 |
Wyeth John & Brother Ltd |
Aminoacetamide-pyridyl-tetrahydropyridyl and-piperidyl derivatives
|
|
US4147786A
(en)
*
|
1976-02-02 |
1979-04-03 |
Ciba-Geigy Corporation |
1-Indolylalkyl-3-or 4-trimethyleneurido-piperidines
|
|
US4163789A
(en)
*
|
1976-02-17 |
1979-08-07 |
Anphar, S.A. |
Anti-psychotic (cycloalkenylalkylpiperidino) benzamides
|
|
GB1542137A
(en)
*
|
1976-03-12 |
1979-03-14 |
Wyeth John & Brother Ltd |
Process for preparing 3(piperidinoalkyl)indoles
|
|
GB1581620A
(en)
*
|
1977-02-23 |
1980-12-17 |
Sekisui Chemical Co Ltd |
Gas combustion system
|
|
EP0007399B1
(de)
|
1978-06-24 |
1982-01-20 |
MERCK PATENT GmbH |
Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
|
|
US4242347A
(en)
*
|
1979-06-18 |
1980-12-30 |
Ciba-Geigy Corporation |
Hypotensive indolylalkylpiperidyl guanidines and isoureas
|
|
US4428954A
(en)
|
1980-11-01 |
1984-01-31 |
John Wyeth And Brother Limited |
Method for treatment of cerebrovascular disorders
|
|
ZA822995B
(en)
*
|
1981-05-21 |
1983-12-28 |
Wyeth John & Brother Ltd |
Slow release pharmaceutical composition
|
|
FR2530632A1
(fr)
*
|
1982-07-26 |
1984-01-27 |
Bouchara Emile |
Nouveaux derives substitues du 2,5-diamino 1,4-diazole, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
|
|
DE3301758A1
(de)
*
|
1983-01-20 |
1984-07-26 |
Merck Patent Gmbh, 6100 Darmstadt |
Indolderivate
|
|
JPS6084281A
(ja)
*
|
1983-09-14 |
1985-05-13 |
Yoshitomi Pharmaceut Ind Ltd |
３−インド−ルカルボキサミド類
|
|
JPS60123485A
(ja)
*
|
1983-12-08 |
1985-07-02 |
Yoshitomi Pharmaceut Ind Ltd |
インド−ル−３−カルボキサミド誘導体
|
|
JPS60142981A
(ja)
*
|
1983-12-28 |
1985-07-29 |
Yoshitomi Pharmaceut Ind Ltd |
３−インド−ルカルボキサミド誘導体
|
|
GB8406089D0
(en)
*
|
1984-03-08 |
1984-04-11 |
Wyeth John & Brother Ltd |
Treatment/prevention of atherosclerotic disorders &c
|
|
US4569933A
(en)
*
|
1984-04-13 |
1986-02-11 |
Cornu Pierre Jean |
Antihypertensive substituted derivatives of 2,5-diamino 1,4-diazole
|
|
PH23498A
(en)
*
|
1984-08-06 |
1989-08-16 |
Sterling Drug Inc |
3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
|
|
GB8422924D0
(en)
*
|
1984-09-11 |
1984-10-17 |
Wyeth John & Brother Ltd |
Prevention of hypertension
|
|
EP0187619A3
(de)
*
|
1985-01-03 |
1987-08-26 |
Ciba-Geigy Ag |
1,3-disubstituierte Tetrahydropyridine
|
|
EP0187122A3
(de)
*
|
1985-01-03 |
1987-12-16 |
Ciba-Geigy Ag |
1,3,4-Trisubstituierte Azacycloalkane bzw. Azacycloalkene
|
|
GB8531665D0
(en)
*
|
1985-12-23 |
1986-02-05 |
Wyeth John & Brother Ltd |
Indole derivatives
|
|
GB8531666D0
(en)
*
|
1985-12-23 |
1986-02-05 |
Wyeth John & Brother Ltd |
Indole derivatives
|
|
US4757079A
(en)
*
|
1986-06-24 |
1988-07-12 |
Dynamac Corporaton |
Anti-hypertensive piperidine compounds
|
|
US5004812A
(en)
*
|
1987-06-26 |
1991-04-02 |
E. I. Du Pont De Nemours And Company |
Direct positive dimethine cyanine dyes containing 1-aryl-2-heteroaryl indole nucleus
|
|
GB8903036D0
(en)
*
|
1989-02-10 |
1989-03-30 |
Glaxo Group Ltd |
Chemical compounds
|
|
NZ241979A
(en)
*
|
1991-03-20 |
1996-01-26 |
Merck & Co Inc |
Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker
|
|
US5468768A
(en)
*
|
1994-01-06 |
1995-11-21 |
Bristol-Myers Squibb Company |
Antimigraine derivatives of indolylcycloalkanylamines
|
|
AU3162695A
(en)
*
|
1994-08-03 |
1996-03-04 |
Asta Medica Aktiengesellschaft |
Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
|
|
WO1999055696A1
(de)
|
1998-04-28 |
1999-11-04 |
Arzneimittelwerk Dresden Gmbh |
Neue hydroxyindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung
|
|
CN1163224C
(zh)
|
1998-09-30 |
2004-08-25 |
武田药品工业株式会社 |
改善膀胱排泄能力的药物
|
|
US20020065286A1
(en)
*
|
2000-08-21 |
2002-05-30 |
Davies Michael John |
Treatment of wounds
|
|
US20020091129A1
(en)
*
|
2000-11-20 |
2002-07-11 |
Mitradev Boolell |
Treatment of premature ejaculation
|
|
GB0130219D0
(en)
*
|
2001-12-18 |
2002-02-06 |
Pfizer Ltd |
Compounds for the treatment of sexual dysfunction
|
|
US20030229001A1
(en)
*
|
2002-01-31 |
2003-12-11 |
Pfizer Inc. |
Treatment of male sexual dysfunction
|
|
EP1545519B1
(de)
|
2002-08-19 |
2011-03-23 |
Pfizer Inc. |
Kombinationstherapie gegen hyperproliferative erkrankungen
|
|
GB0219961D0
(en)
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
|
US7323462B2
(en)
*
|
2002-12-10 |
2008-01-29 |
Pfizer Inc. |
Morpholine dopamine agonists
|
|
CA2451267A1
(en)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
PA8597401A1
(es)
*
|
2003-03-14 |
2005-05-24 |
Pfizer |
Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
|
|
US20040220186A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
SG141430A1
(en)
|
2003-05-30 |
2008-04-28 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as hmg-co inhibitors
|
|
US20050065158A1
(en)
*
|
2003-07-16 |
2005-03-24 |
Pfizer Inc. |
Treatment of sexual dysfunction
|
|
US7291640B2
(en)
*
|
2003-09-22 |
2007-11-06 |
Pfizer Inc. |
Substituted triazole derivatives as oxytocin antagonists
|
|
US20050267096A1
(en)
*
|
2004-05-26 |
2005-12-01 |
Pfizer Inc |
New indazole and indolone derivatives and their use pharmaceuticals
|
|
US20050288270A1
(en)
*
|
2004-05-27 |
2005-12-29 |
Pfizer Inc |
New aminopyridine derivatives and their use as pharmaceuticals
|
|
US20060063803A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Pfizer Inc |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
|
|
WO2006100557A1
(en)
*
|
2005-03-21 |
2006-09-28 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
|
US20080214622A1
(en)
*
|
2005-03-21 |
2008-09-04 |
Alan Daniel Brown |
Substituted Triazole Derivatives As Oxytocin Antagonists
|
|
EP1917257A1
(de)
*
|
2005-08-10 |
2008-05-07 |
Pfizer Limited |
Substituierte triazolderivate als oxytocin-antagonisten
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
AU2006313430B2
(en)
|
2005-11-08 |
2012-09-06 |
Ranbaxy Laboratories Limited |
Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
US8383660B2
(en)
|
2006-03-10 |
2013-02-26 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
|
JP5498168B2
(ja)
|
2006-12-01 |
2014-05-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
|
|
EP2427430B1
(de)
|
2009-05-04 |
2014-09-10 |
The Royal Institution for the Advancement of Learning/McGill University |
5-oxo-ete-rezeptorantagonistverbindungen
|
|
WO2014170786A1
(en)
|
2013-04-17 |
2014-10-23 |
Pfizer Inc. |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
CN110770224B
(zh)
*
|
2017-03-10 |
2022-11-18 |
罗格斯新泽西州立大学 |
作为外排泵抑制剂的吲哚衍生物
|
|
JOP20210193A1
(ar)
|
2019-01-18 |
2023-01-30 |
Astrazeneca Ab |
مثبطات pcsk9 وطرق استخدامها
|